NCT01609959View on ClinicalTrials.gov

New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

September 30, 2013

Study Completion Date

October 31, 2013

Conditions
Hypertension
Interventions
DRUG

Azilsartan

Azilsartan 20 mg or 40 mg (if blood pressure does not reach the target after 6 weeks) per day for 12 weeks

DRUG

Valsartan

Valsartan 160 mg per day

Trial Locations (1)

634-8522

First Department of Nara Medical University, Kashihara

Sponsors
All Listed Sponsors
lead

Nara Medical University

OTHER